Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620746 · ClinicalTrials.gov registry record · Phase 4
Penicillin Allergy Testing in STD Clinics
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 284
- Enrollment target
NCT04620746: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT04620746 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 284 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04620746, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 284 participants
- Enrollment target
Study Summary
Demonstration project to implement penicillin allergy testing in STD outpatients using a questionnaire and pen allergy testing
Interventions
- DRUG Penicillin Major Determinant (PrePen) Skin Testing
- DRUG Direct Oral challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04620746
The ClinicalTrials.gov registry entry for NCT04620746 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Penicillin Major Determinant (PrePen) Skin Testing is the first listed.
NCT04620746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04620746 about?
NCT04620746 is a clinical study titled "Penicillin Allergy Testing in STD Clinics". Demonstration project to implement penicillin allergy testing in STD outpatients using a questionnaire and pen allergy testing
What is the current status of trial NCT04620746?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 284 participants. The study started on 2021-06-01. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04620746?
The interventions under investigation include: Penicillin Major Determinant (PrePen) Skin Testing (DRUG), Direct Oral challenge (DRUG).
Who is sponsoring clinical trial NCT04620746?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.